Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Senseonics Holdings (SENS)

Senseonics Holdings (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 281,838
  • Shares Outstanding, K 530,668
  • Annual Sales, $ 22,390 K
  • Annual Income, $ -60,390 K
  • 60-Month Beta 0.90
  • Price/Sales 13.36
  • Price/Cash Flow N/A
  • Price/Book 8.36
Trade SENS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings $-0.03 on 02/29/24
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 198.08% ( +139.25%)
  • Historical Volatility 77.82%
  • IV Percentile 88%
  • IV Rank 38.03%
  • IV High 516.52% on 11/29/23
  • IV Low 2.66% on 01/16/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 369
  • Volume Avg (30-Day) 672
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 43,046
  • Open Int (30-Day) 43,423

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5300 +0.21%
on 03/28/24
0.7480 -29.00%
on 02/29/24
-0.1692 (-24.16%)
since 02/28/24
3-Month
0.5010 +6.01%
on 01/17/24
0.7500 -29.19%
on 02/26/24
-0.0397 (-6.96%)
since 12/28/23
52-Week
0.4606 +15.31%
on 10/30/23
1.0500 -49.42%
on 07/19/23
-0.1801 (-25.32%)
since 03/28/23

Most Recent Stories

More News
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...

SENS : 0.5311 (-5.77%)
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 35.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SENS : 0.5311 (-5.77%)
NYXH : 13.49 (+1.73%)
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEM

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive...

SENS : 0.5311 (-5.77%)
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.5311 (-5.77%)
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) system portfolio and exclusive...

SENS : 0.5311 (-5.77%)
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.5311 (-5.77%)
Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) system for people...

SENS : 0.5311 (-5.77%)
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.5311 (-5.77%)
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates

Sol-Gel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of -92.31% and 94.60%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

SLGL : 0.9801 (+0.01%)
SENS : 0.5311 (-5.77%)
Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of 50% and 1.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HCAT : 7.53 (+1.21%)
SENS : 0.5311 (-5.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 0.5974
2nd Resistance Point 0.5837
1st Resistance Point 0.5574
Last Price 0.5311
1st Support Level 0.5174
2nd Support Level 0.5037
3rd Support Level 0.4774

See More

52-Week High 1.0500
Fibonacci 61.8% 0.8248
Fibonacci 50% 0.7553
Fibonacci 38.2% 0.6858
Last Price 0.5311
52-Week Low 0.4606

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar